MV-833

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMV-833
Drug Alias NamehuMV 833Anti-VEGF monoclonal antibody - ToagoseiSMART anti-VEGF monoclonal antibodySMART anti-VEGFAnti-vascular endothelial growth factor monoclonal antibody - Toagosei
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionAngiogenesis inhibitorsVascular endothelial growth factor A inhibitors
TargetsVascular endothelial growth factor A
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesToagosei
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesToagoseiPdl Biopharma Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A